These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 22091305)

  • 1. The prevalence of metabolic syndrome and insulin resistance according to the phenotypic subgroups of polycystic ovary syndrome in a representative sample of Iranian females.
    Mehrabian F; Khani B; Kelishadi R; Kermani N
    J Res Med Sci; 2011 Jun; 16(6):763-9. PubMed ID: 22091305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Prevalence of Polycystic Ovary Syndrome, Its Phenotypes and Cardio-Metabolic Features in a Community Sample of Iranian Population: Tehran Lipid and Glucose Study.
    Farhadi-Azar M; Behboudi-Gandevani S; Rahmati M; Mahboobifard F; Khalili Pouya E; Ramezani Tehrani F; Azizi F
    Front Endocrinol (Lausanne); 2022; 13():825528. PubMed ID: 35299965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria.
    Goverde AJ; van Koert AJ; Eijkemans MJ; Knauff EA; Westerveld HE; Fauser BC; Broekmans FJ
    Hum Reprod; 2009 Mar; 24(3):710-7. PubMed ID: 19095675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
    Jamil AS; Alalaf SK; Al-Tawil NG; Al-Shawaf T
    Reprod Health; 2015 Jan; 12():7. PubMed ID: 25595199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic aspects of different phenotypes of polycystic ovary syndrome: Iranian PCOS Prevalence Study.
    Hosseinpanah F; Barzin M; Keihani S; Ramezani Tehrani F; Azizi F
    Clin Endocrinol (Oxf); 2014 Jul; 81(1):93-9. PubMed ID: 24428207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist Endocrine Clinic.
    Wijeyaratne CN; Seneviratne Rde A; Dahanayake S; Kumarapeli V; Palipane E; Kuruppu N; Yapa C; Seneviratne Rde A; Balen AH
    Hum Reprod; 2011 Jan; 26(1):202-13. PubMed ID: 21098627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lack of association between polycystic ovary syndrome and metabolic syndrome: Iranian PCOS prevalence study.
    Hosseinpanah F; Barzin M; Tehrani FR; Azizi F
    Clin Endocrinol (Oxf); 2011 Nov; 75(5):692-7. PubMed ID: 21592169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Could "a body shape index" and "waist to height ratio" predict insulin resistance and metabolic syndrome in polycystic ovary syndrome?
    Behboudi-Gandevani S; Ramezani Tehrani F; Cheraghi L; Azizi F
    Eur J Obstet Gynecol Reprod Biol; 2016 Oct; 205():110-4. PubMed ID: 27579518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of metabolic syndrome in four phenotypes of PCOS and its relationship with androgenic components among Iranian women: A cross-sectional study.
    Zaeemzadeh N; Sadatmahalleh SJ; Ziaei S; Kazemnejad A; Mottaghi A; Mohamadzadeh N; Movahedinejad M
    Int J Reprod Biomed; 2020 Apr; 18(4):253-264. PubMed ID: 32494764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Contribution of hyperandrogenism to the development of metabolic syndrome in obese women with polycystic ovary syndrome].
    Rehme MF; Pontes AG; Corrente JE; Franco JG; Pontes A
    Rev Bras Ginecol Obstet; 2013 Dec; 35(12):562-8. PubMed ID: 24500511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome and metabolic risk profile according to polycystic ovary syndrome phenotype.
    Bil E; Dilbaz B; Cirik DA; Ozelci R; Ozkaya E; Dilbaz S
    J Obstet Gynaecol Res; 2016 Jul; 42(7):837-43. PubMed ID: 27071345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of metabolic syndrome among Iranian women with polycystic ovary syndrome: A systematic review and meta-analysis.
    Niksima SH; Odel NM; Khaki S; Ghanei Gheshlagh R; Fallahi A; Kurdi A
    Diabetes Metab Syndr; 2019; 13(3):1911-1915. PubMed ID: 31235114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome in Mediterranean women with polycystic ovary syndrome: when and how to predict its onset.
    Espinós-Gómez JJ; Rodriguez-Espinosa J; Ordóñez-Llanos J; Calaf-Alsina J
    Gynecol Endocrinol; 2012 Apr; 28(4):264-8. PubMed ID: 21962027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing classic and newer phenotypes in Greek PCOS women: the prevalence of metabolic syndrome and their association with insulin resistance.
    Vaggopoulos V; Trakakis E; Chrelias C; Panagopoulos P; Basios G; Makridima S; Sioulas VD; Simeonides G; Labos G; Boutati E; Kassanos D
    J Endocrinol Invest; 2013; 36(7):478-84. PubMed ID: 23211631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of metabolic syndrome in women with polycystic ovary syndrome and the factors associated: A cross sectional study at a tertiary care center in Hyderabad, south-eastern India.
    Karee M; Gundabattula SR; Sashi L; Boorugu H; Chowdhury A
    Diabetes Metab Syndr; 2020; 14(4):583-587. PubMed ID: 32416528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of insulin resistance with polycystic ovary syndrome phenotypes and patients' characteristics: a cross-sectional study in Iran.
    Rahmatnezhad L; Moghaddam-Banaem L; Behroozi-Lak T; Shiva A; Rasouli J
    Reprod Biol Endocrinol; 2023 Nov; 21(1):113. PubMed ID: 38001527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic subgroups of polycystic ovary syndrome have different intra-renal resistance symptoms.
    Ciftci CF; Uckuyu A; Karadeli E; Turhan E; Toprak E; Ozcimen EE
    Ginekol Pol; 2012 Dec; 83(12):910-5. PubMed ID: 23488293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of metabolic syndrome in women with polycystic ovary syndrome.
    Panidis D; Macut D; Tziomalos K; Papadakis E; Mikhailidis K; Kandaraki EA; Tsourdi EA; Tantanasis T; Mavromatidis G; Katsikis I
    Clin Endocrinol (Oxf); 2013 Apr; 78(4):586-92. PubMed ID: 22888988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of metabolic syndrome is higher among non-obese PCOS women with hyperandrogenism and menstrual irregularity in Korea.
    Kim MJ; Lim NK; Choi YM; Kim JJ; Hwang KR; Chae SJ; Park CW; Choi DS; Kang BM; Lee BS; Kim T; Park HY
    PLoS One; 2014; 9(6):e99252. PubMed ID: 24901345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.
    Tziomalos K; Katsikis I; Papadakis E; Kandaraki EA; Macut D; Panidis D
    Hum Reprod; 2013 Mar; 28(3):785-93. PubMed ID: 23315058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.